Results 61 to 70 of about 1,335,871 (234)

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up [PDF]

, 2017
This manuscript provides recommendations for the diagnosis, treatment and follow-up of early stage non-small cell lung cancer developed during the 2nd ESMO Consensus Conference on Lung Cancer in May ...
Adjei, Alex, Baas, Paul, Besse, Benjamin, Bubendorf, Lukas, Crinò, L., Crinò, Lucio, De Leyn, Paul, De Ruysscher, Dirk, Dooms, C., Dooms, Christophe, Douillard, J. Y., Douillard, Jean-Yves, Eberhardt, Wilfried, Edelman, Martin, Faivre-Finn, C., Faivre-Finn, Corinne, Felip, E., Felip, Enriqueta, Kerr, Keith, Le Pechoux, Cecile, Lim, E., Lim, Eric, Marchetti, Antonio, Meldgaard, Peter, Mok, Tony, Nicolson, Marianne, Novello, Silvia, O'Byrne, Ken, Paz-Ares, Luis, Peters, S., Peters, Solange, Reck, Martin, Rocco, G., Rocco, Gaetano, Senan, S., Senan, Suresh, Smit, Egbert F., Stahel, R., Stahel, Rolf, Syrigos, Konstantinos, Van Schil, P., Van Schil, Paul, Vansteenkiste, J., Vansteenkiste, Johan, Veronesi, G., Veronesi, Giulia, Weder, Walter, Westeel, Virginie   +47 more
core  

Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments. [PDF]

, 2018
In this study we utilized data on patient responses to guided treatments, and we evaluated their benefit for a non-small cell lung cancer cohort. The recommended therapies used were predicted using tumor molecular profiles that involved a range of ...
Alifrangis, C, Belluz, LDB, Carter, P, Cereser, B, Chandrasinghe, P, Krell, J, Lim, E, Moderau, N, Poyia, F, Stebbing, J, Tabassum, N, Zhang, H   +11 more
core   +2 more sources

Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer.

New England Journal of Medicine, 2019
BACKGROUND In an early-phase study involving patients with advanced non-small-cell lung cancer (NSCLC), the response rate was better with nivolumab plus ipilimumab than with nivolumab monotherapy, particularly among patients with tumors that expressed ...
M. Hellmann, L. Paz-Ares, R. Bernabé Caro, B. Żurawski, Sang-We Kim, E. Carcereny Costa, Keunchil Park, A. Alexandru, L. Lupinacci, Emmanuel de la Mora Jimenez, H. Sakai, I. Albert, A. Vergnenègre, S. Peters, K. Syrigos, F. Barlesi, M. Reck, H. Borghaei, J. Brahmer, K. O'Byrne, W. Geese, P. Bhagavatheeswaran, S. Rabindran, Ravi S. Kasinathan, F. Nathan, S. Ramalingam   +25 more
semanticscholar   +1 more source

Usability and Feasibility of Chest Perfusion Computed Tomography in Differentiating Small Cell Lung Cancer and Non-Small Cell Lung Cancer

Archives of Basic and Clinical Research
Objective: We aimed to investigate to usability and feasibility of perfusion computerized tomography (PCT) in differentiating small cell lung cancer (SCLC) from non-small cell lung cancer (NSCLC).
Ömer Özyiğit, Suat Eren
doaj   +1 more source

Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe [PDF]

, 2001
Background: Since the incidence of the histological subtypes of lung cancer in industrialised countries has changed dramatically over the last two decades, we reviewed trends in the incidence and prognosis in North America, Australia, New Zealand and ...
Coebergh, J.W.W. (Jan Willem), Janssen-Heijnen, M.L.G. (Maryska)   +1 more
core   +3 more sources

Chemotherapy for advanced non-small-cell lung cancer: Role of paclitaxel and gemcitabine [PDF]

, 1999
Objective. To review the role of chemotherapy in advanced non-small-cell lung cancer, focusing on cisplatin-based regimens and two new drugs: paclitaxel and gemcitabine. Data sources. Medline search of the relevant English literature.
Ip, MSM, Lam, WK, Tsang, KWT
core  

Effects of Coptis extract combined with chemotherapeutic agents on ROS production, multidrug resistance, and cell growth in A549 human lung cancer cells [PDF]

, 2012
Background: Non–small cell lung cancer is associated with high expression of multidrug resistance (MDR) proteins and low production of reactive oxygen species (ROS).
He, Chengwei, Kang, Jing Xuan, Liu, Jing, Rong, Rong, Wan, Jianbo, Zhou, Keyuan   +5 more
core   +2 more sources

Maintenance therapies for non small cell lung cancer

Frontiers in Oncology, 2014
Treatment of lung cancer had evolved during the last decade with the introduction of new chemotherapeutic regimens and targeted therapies. However, the maximum benefit reached after first line therapy is limited by the cumulative toxicity of platinum ...
Normand eBlais, Elie eKassouf
doaj   +1 more source

Increased HAGLR expression promotes non–small cell lung cancer proliferation and invasion via enhanced de novo lipogenesis

Tumor Biology, 2017
Lung cancers are broadly classified into small cell lung cancer and non–small cell lung cancer, with non–small cell lung cancer one of the leading causes of cancer-associated deaths worldwide.
Chunwei Lu, Jun Ma, Dingfang Cai
doaj   +1 more source

Update in non small- cell lung cancer staging

Journal of the Belgian Society of Radiology, 2013
Significant progress has been made with the introduction of the TNM-7 staging system for non-small cell lung cancer (NSCLC). Constituting the first major revision in 12 years, the seventh edition of NSCLC TNM (TNM-7) is based on the recommendations from ...
RA Salgado, A Snoeckx, M Spinhoven, B Op de Beeck, B Corthouts, PM Parizel   +5 more
doaj   +1 more source